194700 — Novarex Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapContrarian

Market Cap
KR₩168bn
Enterprise Value
KR₩161bn
Revenue
KR₩302bn

Annual income statement for Novarex Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	159,101	222,832	278,790	281,675	302,167
Cost of Revenue
Gross Profit	28,615	39,203	41,443	40,417	43,932
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	142,795	195,839	248,778	256,647	276,697
Operating Profit	16,306	26,993	30,012	25,028	25,470
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	17,015	26,801	30,648	24,245	26,142
Provision for Income Taxes
Net Income After Taxes	14,506	25,000	26,313	19,942	21,974
Minority Interest
Net Income Before Extraordinary Items
Net Income	14,709	25,145	26,401	19,986	22,036
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	14,709	25,145	26,401	19,986	22,036
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	917	1,554	1,636	1,216	1,249
Dividends per Share